Values as of: 2025-04-15
COMMON STOCK | Healthcare Plans |
Last Closing
USD 286.78Change
+1.96 (+0.69)%Market Cap
N/AVolume
1.15MAnalyst Target
USD 448.08
N/A
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| UNH | UnitedHealth Group Incorporate.. |
-3.47 (-0.59%) |
USD 446.97B |
| ELV | Elevance Health Inc |
-3.40 (-0.77%) |
USD 99.57B |
| CNC | Centene Corp |
-0.73 (-1.16%) |
USD 28.86B |
| MOH | Molina Healthcare Inc |
-13.07 (-3.75%) |
USD 17.11B |
| OSCR | Oscar Health Inc |
+0.03 (+0.24%) |
USD 3.26B |
| NEUE | NeueHealth Inc |
-0.24 (-3.61%) |
USD 0.05B |
| CI | Cigna Corp |
-0.57 (-0.17%) |
N/A |
| CVS | CVS Health Corp |
-0.28 (-0.40%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| TUSB:CA | TD Select U.S. Short Term.. | 2.16 % | 0.28 % |
-0.03 (-1.14%) |
CAD 0.02B |
| TUSB-U:CA | TD Select U.S. Short Term.. | 2.16 % | 0.00 % |
+0.04 (+-1.14%) |
CAD 8.25M |
| SRHQ | Elevation Series Trust - .. | 1.84 % | 0.00 % |
-0.09 (-1.14%) |
N/A |
| RSPH | Invesco S&P 500 Equal Wei.. | 1.80 % | 0.00 % |
-0.32 (-1.14%) |
USD 0.80B |
| RSPE | Invesco Exchange-Traded F.. | 0.70 % | 0.00 % |
-0.14 (-1.14%) |
USD 0.03B |
| CVMC | Morgan Stanley ETF Trust .. | 0.50 % | 0.00 % |
-0.15 (-1.14%) |
N/A |
| EUSA | iShares MSCI USA Equal We.. | 0.23 % | 0.15 % |
-0.09 (-1.14%) |
USD 1.29B |
| FUM:CA | 0.00 % | 0.80 % |
N/A |
N/A | |
| IHF | iShares U.S. Healthcare P.. | 0.00 % | 0.43 % |
-0.41 (-1.14%) |
N/A |
| MUS:CA | 0.00 % | 0.58 % |
N/A |
N/A | |
| ONEV | SPDR® Russell 1000 Low V.. | 0.00 % | 0.20 % |
-0.59 (-1.14%) |
N/A |
| VETS | 0.00 % | 0.60 % |
N/A |
N/A | |
| HIG-U:CA | 0.00 % | 0.00 % |
N/A |
N/A | |
| GBLO | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Healthcare Plans) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 13.03% | 44% | F | 94% | A | ||
| Dividend Return | 0.35% | 20% | F | 15% | F | ||
| Total Return | 13.38% | 44% | F | 94% | A | ||
| Trailing 12 Months | |||||||
| Capital Gain | -9.68% | 44% | F | 26% | F | ||
| Dividend Return | 1.39% | 40% | F | 27% | F | ||
| Total Return | -8.29% | 44% | F | 24% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -23.99% | 17% | F | 14% | F | ||
| Dividend Return | 4.42% | 25% | F | 8% | B- | ||
| Total Return | -19.57% | 17% | F | 11% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -4.07% | 11% | F | 17% | F | ||
| Dividend Return | -3.36% | 11% | F | 12% | F | ||
| Total Return | 0.71% | 40% | F | 17% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 20.72% | 78% | C+ | 50% | F | ||
| Risk Adjusted Return | -16.20% | 22% | F | 13% | F | ||
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector
